H Ross-Adams
H Ross-Adams
aCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK
a,1,
AD Lamb
AD Lamb
aCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK
bDepartment of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK
cAcademic Urology Group, University of Cambridge, Cambridge, CB2 0QQ, UK
a,b,c,⁎,1,
MJ Dunning
MJ Dunning
aCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK
a,1,
S Halim
S Halim
aCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK
a,
J Lindberg
J Lindberg
dDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
d,
CM Massie
CM Massie
aCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK
a,
LA Egevad
LA Egevad
eDepartment of Oncology–Pathology, Karolinska Institutet, Stockholm, Sweden
e,
R Russell
R Russell
aCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK
a,
A Ramos-Montoya
A Ramos-Montoya
aCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK
a,
SL Vowler
SL Vowler
aCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK
a,
NL Sharma
NL Sharma
fNuffield Department of Surgical Sciences, University of Oxford, Roosevelt Drive, Oxford, UK
f,
J Kay
J Kay
aCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK
gMolecular Diagnostics and Therapeutics Group, University College London, WC1E 6BT, UK
a,g,
H Whitaker
H Whitaker
aCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK
gMolecular Diagnostics and Therapeutics Group, University College London, WC1E 6BT, UK
a,g,
J Clark
J Clark
hUniversity of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK
h,
R Hurst
R Hurst
hUniversity of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK
h,
VJ Gnanapragasam
VJ Gnanapragasam
bDepartment of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK
cAcademic Urology Group, University of Cambridge, Cambridge, CB2 0QQ, UK
b,c,
NC Shah
NC Shah
bDepartment of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK
b,
AY Warren
AY Warren
iDepartment of Pathology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK
i,
CS Cooper
CS Cooper
hUniversity of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK
h,
AG Lynch
AG Lynch
aCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK
a,
R Stark
R Stark
aCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK
a,
IG Mills
IG Mills
aCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK
jProstate Cancer Research Group, Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, Norway
kDepartment of Molecular Oncology, Institute of Cancer Research, Oslo University Hospitals, N-0424 Oslo, Norway
lProstate Cancer UK/Movember Centre of Excellence for Prostate Cancer Research, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK
a,j,k,l,
H Grönberg
H Grönberg
dDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
d,1,
DE Neal
DE Neal
aCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK
bDepartment of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK
a,b,1;
on behalf of the CamCaP Study Group2
aCancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK
bDepartment of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK
cAcademic Urology Group, University of Cambridge, Cambridge, CB2 0QQ, UK
dDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
eDepartment of Oncology–Pathology, Karolinska Institutet, Stockholm, Sweden
fNuffield Department of Surgical Sciences, University of Oxford, Roosevelt Drive, Oxford, UK
gMolecular Diagnostics and Therapeutics Group, University College London, WC1E 6BT, UK
hUniversity of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK
iDepartment of Pathology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK
jProstate Cancer Research Group, Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, Norway
kDepartment of Molecular Oncology, Institute of Cancer Research, Oslo University Hospitals, N-0424 Oslo, Norway
lProstate Cancer UK/Movember Centre of Excellence for Prostate Cancer Research, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK
⁎Corresponding author. Alastair.Lamb@cruk.cam.ac.uk
1These authors contributed equally to this work.
2List of participants and affiliations appear at the end of the paper.
Collection date 2017 Mar.
Crown Copyright © 2017 Published by Elsevier B.V.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
